|

Maribavir Clinical Trials

2 actively recruiting trials

No change since May 2026

Pipeline

Phase 2: 1Phase 3: 1

Top Sponsors

  • Seoul National University Hospital1
  • Ruijin Hospital1

Indications

  • Cancer2
  • Cytomegalovirus (CMV)1
  • Hematologic Malignancy1

Other2 trials

Comparing the Efficacy of Different Durations of Maribavir Treatment Regimens in Allo-HSCT
Phase 3
Phase II Trial of Maribavir for CMV in Patients With Lymphoid Malignancy on Bispecific Antibodies
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.